Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |